Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis

British Journal of Cancer

Volumn 102, Issue 12, 2010, Pages 1731-1735

  Cho, W C S ^a   Yip, T T ^b   Cheng, W W ^a   Au, J S K ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b CIPHERGEN BIOSYSTEMS INC   (United States)

Author keywords

Lung cancer; Proteinchip; Proteomics; SELDI TOF MS; Serum amyloid A; Serum biomarker

Indexed keywords

BIOLOGICAL MARKER; SERUM AMYLOID A;

AGED; ARTICLE; BLOOD DONOR; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FRAGMENTATION REACTION; HUMAN; IMMUNOASSAY; INFLAMMATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SURVIVAL RATE; SURVIVAL TIME; TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION PROCESS;

AGED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SERUM AMYLOID A PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 77953286172     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605700     Document Type: Article

References (27)

1. Au JS, Cho WC, Yip TT, Law SC (2008) Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong. Cancer Invest 26: 128-135
2. Chan DC, Chen CJ, Chu HC, Chang WK, Yu JC, Chen YJ, Wen LL, Huang SC, Ku CH, Liu YC, Chen JH (2007) Evaluation of serum amyloid A as a biomarker for gastric cancer. Ann Surg Oncol 14: 84-93
3. Cho WC (2007a) Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer. Biomed Pharmacother 61: 515-519
4. Cho WC (2007b) Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 6: 25
5. Cho WC (2009) Proteinchip. In Encyclopedia of Cancer, Schwab M (ed). 2nd edn, Vol.3, pp 2475-2478. Springer: New York
6. Cho WC (2010a) Cancer biomarkers (an overview). In Methods of Cancer Diagnosis, Therapy and Prognosis, Hayat MA (ed). Springer: New York, pp 21-40
7. Cho WC (2010b) Omics approaches in cancer research. In An Omics Perspective on Cancer Research, Cho WC (ed). Springer: New York, pp 1-9.
8. Cho WC, Cheng CH (2007) Oncoproteomics: current trends and future perspectives. Expert Rev Proteomics 4: 401-410
9. Cho WC, Yip TT, Ngan RK, Yip TT, Podust VN, Yip C, Yiu HH, Yip V, Cheng WW, Ma VW, Law SC (2007) Proteinchip array profiling for identification of disease-and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. Clin Chem 53: 241-250
10. Cho WC, Yip TT, Yip C, Yip V, Thulasiraman V, Ngan RK, Yip TT, Lau WH, Au JS, Law SC, Cheng WW, Ma VW, Lim CK (2004) Identification of serum amyloid A protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer Res 10: 43-52
11. Cocco E, Bellone S, El-Sahwi K, Cargnelutti M, Buza N, Tavassoli FA, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD (2010) Serum amyloid A: a novel biomarker for endometrial cancer. Cancer 116: 843-851
12. Cocco E, Bellone S, El-Sahwi K, Cargnelutti M, Casagrande F, Buza N, Tavassoli FA, Siegel ER, Visintin I, Ratner E, Silasi D-A, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD (2009) Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer. Bri J Cancer 101: 335-341
13. Cohen AA, Geva-Zatorsky N, Eden E, Frenkel-Morgenstern M, Issaeva I, Sigal A, Milo R, Cohen-Saidon C, Liron Y, Kam Z, Cohen L, Danon T, Perzov N, Alon U (2008) Dynamic proteomics of individual cancer cells in response to a drug. Science 322: 1511-1516
14. Findeisen P, Zapatka M, Peccerella T, Matzk H, Neumaier M, Schadendorf D, Ugurel S (2009) Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling. J Clin Oncol 27: 2199-2208
15. Fung ET (2010) A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance. Clin Chem 56: 327-329
16. Gámez-Pozo A, Sánchez-Navarro I, Nistal M, Calvo E, Madero R, D́iaz E, Camafeita E, de Castro J, López JA, González-Barón M, Espinosa E Fresno Vara JA (2009) MALDI profiling of human lung cancer subtypes. PLoS One 4: e7731
17. Gilbert K, Figueredo S, Meng XY, Yip C, Fung ET (2004) Serum protein-expression profiling using the proteinchip biomarker system. In Methods in Molecular Biology. Vol 264. Protein Arrays Methods and Protocols Fung ET (ed), pp 259-268. Humana Press Inc: Totowa
18. Gutfeld O, Prus D, Ackerman Z, Dishon S, Linke RP, Levin M, Urieli-Shoval S (2006) Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis. J Histochem Cytochem 54: 63-73
19. Han MK, Oh YH, Kang J, Kim YP, Seo S, Kim J, Park K, Kim HS (2009) Protein profiling in human sera for identification of potential lung cancer biomarkers using antibody microarray. Proteomics 9: 5544-5552
20. He QY, Zhu R, Lei T, Ng MY, Luk JM, Sham P, Lau GK, Chiu JF (2008) Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma. J Cell Biochem 103: 740-752
21. Malle E, Sodin-Semrl S, Kovacevic A (2009) Serum amyloid A: an acute-phase protein involved in tumor pathogenesis. Cell Mol Life Sci 66: 9-26
22. Manley PN, Ancsin JB, Kisilevsky R (2006) Rapid recycling of cholesterol: the joint biologic role of C-reactive protein and serum amyloid A. Med Hypotheses 66: 784-792
23. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorensen BE, Tiernan AM, Ulrich CM (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27: 3437-3444
24. Ramankulov A, Lein M, Johannsen M, Schrader M, Miller K, Loening SA, Jung K (2008) Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma. Cancer Lett 269: 85-92
25. Sasazuki S, Inoue M, Sawada N, Iwasaki M, Shimazu T, Yamaji T, Shoichiro T for the Japan Public Health Center-Based Prospective Study Group (2010) Plasma levels of C-reactive protein and serum amyloid A and gastric cancer in a nested casecontrol study: Japan Public Health Center-based prospective study. Carcinogenesis 31: 712-718
26. Tolson J, Bogumil R, Brunst E, Beck H, Elsner R, Humeny A, Kratzin H, Deeg M, Kuczyk M, Mueller GA, Mueller CA, Flad T (2004) Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab Invest 84: 845-856
27. Vermaat JS, van der Tweel I, Mehra N, Sleijfer S, Haanen JB, Roodhart JM, Engwegen JY, Korse CM, Langenberg MH, Kruit W, Groenewegen G, Giles RH, Schellens JH, Beijnen JH, Voest EE (2010) Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models. Ann Oncol; doi: 10.1093/annonc/mdp559